Semaglutide/Tirzepatide Pen (40mg)

$69.50

1 Unit
$69.5 per unit
$69.50
2 Units
$67.76 per unit (save 3% per unit)
$135.52
$139.00
3 Units
$66.03 per unit (save 5% per unit)
$198.09
$208.50
4 Units
$64.29 per unit (save 7% per unit)
$257.16
$278.00
5 Units
$62.55 per unit (save 10% per unit)
$312.75
$347.50
6 Units
$60.81 per unit (save 13% per unit)
$364.86
$417.00
7 Units
$59.08 per unit (save 15% per unit)
$413.56
$486.50
8 Units
$57.34 per unit (save 17% per unit)
$458.72
$556.00
9 Units
$55.6 per unit (save 20% per unit)
$500.40
$625.50
10 Units
$53.86 per unit (save 23% per unit)
$538.60
$695.00
Category:

Description

Tirzepatide and Semaglutide are peptide therapies that offer significant benefits for managing type 2 diabetes and obesity, with Tirzepatide demonstrating slightly superior efficacy in weight loss and glycemic control due to its dual action on GLP-1 and GIP receptors.
Both medications promote weight loss, improve blood sugar regulation, and reduce cardiovascular risk factors, though Tirzepatide’s dual-receptor mechanism provides enhanced metabolic benefits.

Weight Loss: Tirzepatide has shown greater effectiveness in clinical trials, with some participants achieving up to 20% body weight reduction, compared to Semaglutide’s average of around 15%.
Blood Sugar Control: Tirzepatide demonstrates superior HbA1c reduction compared to Semaglutide, particularly in patients with type 2 diabetes, due to its dual agonist activity.
Cardiovascular Benefits: Both drugs reduce cardiovascular risk factors such as high blood pressure, cholesterol levels, and insulin resistance; Tirzepatide may offer additional advantages due to its enhanced metabolic effects.
Appetite and Craving Suppression: Both medications reduce appetite and food intake by acting on brain regions that regulate hunger, but Tirzepatide’s dual action leads to stronger suppression of cravings.
Additional Benefits: Preliminary research suggests potential benefits in treating fatty liver disease and supporting bone health, with Tirzepatide showing protective renal effects such as reduced albuminuria.
Side Effects: Common side effects include nausea, vomiting, and diarrhea due to slowed gastric emptying; however, Tirzepatide may cause less nausea than Semaglutide due to the GIP component.

Related products